37 results
6-K
EX-99.2
SNY
Sanofi
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
Exhibit 99.2
Press Release
Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth
Paris, June 8, 2022. Sanofi … intelligence (AI). Based in Paris, it already brings together a team of over 75 experts from around the world and will continue to recruit top talent
6-K
SNY
Sanofi
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
release dated June 8, 2022: Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth
Exhibit 99.3
Press release dated … Accelerator fueled by new talent and focused on growth
Exhibit 99.3
Press release dated June 13, 2022: Sanofi-GSK next-generation COVID-19 booster
6-K
EX-99.5
SNY
Sanofi
28 Oct 08
Current report (foreign)
12:00am
President of the SIBS.
Page 1 of 3
“We have found a welcoming environment and a huge talent pool in China to expand our R&D activities. Diversity … the development of the Chinese biotechnology industry and become a training base for high quality biotechnology talent. More information on the SIBS
6-K
EX-99.4
SNY
Sanofi
3 Jun 20
Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline
11:27am
Pasteur in 2004 as part of a talent management program and has since held different roles of increasing responsibility in sales and marketing
6-K
EX-99.3
SNY
Sanofi
4 Oct 12
Current report (foreign)
12:00am
, due to its human talent and technology in all of its production processes; having corporate headquarters in Bogota, Colombia, subsidiaries in Peru
6-K
EX-99.2
5lip971
7 Apr 22
If approved, Dupixent would be the first medicine available in the U.S. indicated to treat eosinophilic esophagitis
3:13pm
425
qo54fi
16 Feb 11
Business combination disclosure
12:00am
6-K
EX-99.2
9pmn22ote21nr
1 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.2
y7rkfxfw
29 Jan 13
Current report (foreign)
12:00am
6-K
EX-99.1
z9heijn2 pf7
5 Sep 23
Sanofi announces changes to its Executive Committee
6:19am
425
pqmeb4j1wtppb y2sg3
19 Feb 04
Business combination disclosure
12:00am
SC TO-C
EX-99.1
hupb81 fjmly4l
3 Aug 21
Information about tender offer
5:21pm
6-K
EX-99.1
knl90pafs6qkvpuiwe
3 Aug 21
Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development
5:19pm
425
vtrhv7ulihl17s
19 Feb 04
Business combination disclosure
12:00am
SC TO-C
EX-99.2
qiojsjl
22 Dec 09
Information about tender offer
12:00am